Creation: 07/2025
Employees: 3
Locations / Sites of operation: St Etienne
Field of activity (biotech/medtech/healthtech) : medtech
Who ?
With nearly 200 000 people operated on yearly worldwide, corneal transplantation (keratoplasty) is the most frequent type of transplant. Currently, almost 50% of corneas are discarded due to non-optimal storage conditions. Cornealife is a company dedicated to improving corneal storage. It was created around a product licensed by a large french Pharma group that we will bring to CE-mark and commercialise in Europe and abroad. With our patented bioreactor, eye banks can sell 25% more corneas, contributing to relieving the world of cornea shortage.
Why ?
Heavily implanted in the AURA region with our collaborators and supplier we have that joining Lyon Biopôle will help of connect with startups and industry and further our inclusion into the region.
Dr. Sebastien DÜMCKE, CEO & CTO